AIxMed and PathNet Partner to Advance Digital Pathology With AI-Powered Urine Cytology

AIxMed dedicated to transforming cancer diagnosis and monitoring, together with PathNet, a digital pathology laboratory, has formed a strategic partnership to deploy an AI-powered urine cytology workflow designed to enhance early detection of bladder cancer. The system integrates AIxMed’s AIxURO™ technology with PathNet’s digital pathology network, allowing for automated cytology slide review and classification. The collaboration aims to reduce diagnostic variability, improve turnaround times and support hospitals transitioning from manual to AI-augmented pathology.

The partnership reflects growing adoption of AI in clinical diagnostics. The AIxMed-PathNet alliance focuses specifically on cytology—a diagnostic area historically underserved by digital tools. AIxURO™ assists with the analysis of non-invasive urine cytology specimens to improve diagnostic accuracy of bladder cancer. The collaboration is aimed towards efficiency, enhancement and overall diagnostic improvement.

Posted by MedCloudInsider Editors on 11/04/2025